Article

Nigral pathology and Parkinsonian signs in elders without Parkinson disease

Rush Alzheimer's Disease Center, Chicago, IL, USA.
Annals of Neurology (Impact Factor: 9.98). 02/2012; 71(2):258-66. DOI: 10.1002/ana.22588
Source: PubMed

ABSTRACT

Motor symptoms such as mild parkinsonian signs are common in older persons, but little is known about their underlying neuropathology. We tested the hypothesis that nigral pathology is related to parkinsonism in older persons without Parkinson disease (PD).
More than 2,500 persons participating in the Religious Orders Study or the Memory and Aging Project agreed to annual assessment of parkinsonism with a modified version of the Unified Parkinson Disease Rating Scale and brain donation. Brains from 744 deceased participants without PD were assessed for nigral neuronal loss and α-synuclein immunopositive Lewy bodies.
Mean age at death was 88.5 years. Mean global parkinsonism was 18.6 (standard deviation, 11.90). About ⅓ of cases had mild or more severe nigral neuronal loss, and about 17% had Lewy bodies. In separate regression models that adjusted for age, sex, and education, nigral neuronal loss and Lewy bodies were both related to global parkinsonism (neuronal loss: estimate, 0.231; standard error [SE], 0.068; p < 0.001; Lewy bodies: estimate, 0.291; SE, 0.133; p = 0.029). Employing a similar regression model that included both measures, neuronal loss remained associated with global parkinsonism (neuronal loss: estimate, 0.206; SE, 0.075; p = 0.006). By contrast, the association between Lewy bodies and global parkinsonism was attenuated by >60% and was no longer significant (Lewy bodies: estimate, 0.112; SE, 0.148; p = 0.447), suggesting that neuronal loss may mediate the association of Lewy bodies with global parkinsonism.
Nigral pathology is common in persons without PD and may contribute to loss of motor function in old age.

Download full-text

Full-text

Available from: Sukriti Nag
  • Source
    • "These observations led to the Braak hypothesis, which defines PD as a neurodegenerative diseases that ascends from the dorsal motor nucleus of the vagus nerve, to lower brainstem areas including the ventral midbrain, and finally to neocortical regions[9]. However, the presence of Lewy bodies alone does not explain the onset and progression of PD[10], indicating that a secondary effect triggered by neuronal impairment might be responsible for its progressive nature. Neuroinflammatory reactions have been described in virtually all PD cases, with several studies supporting the hypothesis that microglia-mediated neuroinflammatory responses exacerbate the loss of mDA neurons and, thus, worsen the clinical symptoms[11,12]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Parkinson's disease (PD) is a neurodegenerative disease characterised by histopathological and biochemical manifestations such as loss of midbrain dopaminergic (DA) neurons and decrease in dopamine levels accompanied by a concomitant neuroinflammatory response in the affected brain regions. Over the past decades, the use of toxin-based animal models has been crucial to elucidate disease pathophysiology, and to develop therapeutic approaches aimed to alleviate its motor symptoms. Analyses of transgenic mice deficient for cytokines, chemokine as well as neurotrophic factors and their respective receptors in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD have broadened the current knowledge of neuroinflammation and neurotrophic support. Here, we provide a comprehensive review that summarises the contribution of microglia-mediated neuroinflammation in MPTP-induced neurodegeneration. Moreover, we highlight the contribution of neurotrophic factors as endogenous and/or exogenous molecules to slow the progression of midbrain dopaminergic (mDA) neurons and further discuss the potential of combined therapeutic approaches employing neuroinflammation modifying agents and neurotrophic factors.
    Full-text · Article · Jan 2016 · International Journal of Molecular Sciences
  • Source
    • "Lewy bodies are found in brainstem nuclei in more than 10% of individuals free of PD above age 60 and several lines of evidence argue that they may indicate preclinical stages of PD pathology rather than a by-product of neuronal aging [22, 23]. Clinicopathological studies found reduced nigral cell counts to be associated with increasing signs of subtle motor impairment also in subjects without PD [22] [23]. Individuals with incidental Lewy bodies in the SN and locus coeruleus were found to have loss of neurons in these nuclei as well as loss of tyrosine hydroxylase-positive fibres both in the striatum and epicardial fat which was intermediate between PD and normal controls [24]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Parkinson's disease (PD) is currently clinically defined by a set of cardinal motor features centred on the presence of bradykinesia and at least one additional motor symptom out of tremor, rigidity or postural instability. However, converging evidence from clinical, neuropathological, and imaging research suggests initiation of PD-specific pathology prior to appearance of these classical motor signs. This latent phase of neurodegeneration in PD is of particular relevance in relation to the development of disease-modifying or neuroprotective therapies which would require intervention at the earliest stages of disease. A key challenge in PD research, therefore, is to identify and validate markers for the preclinical and prodromal stages of the illness. Currently, several nonmotor symptoms have been associated with an increased risk to develop PD in otherwise healthy individuals and ongoing research is aimed at validating a variety of candidate PD biomarkers based on imaging, genetic, proteomic, or metabolomic signatures, supplemented by work on tissue markers accessible to minimally invasive biopsies. The definition of diagnostic criteria for prodromal PD will have to include combinations of markers which could define target populations and influence outcomes of future disease modification trials.
    Full-text · Article · Oct 2015
  • Source
    • "Having both, SN-hyperechogenicity and hyposmia, was associated with an odds ratio of 3.0 for incident MPS. A recent clinicopathologic study reported SN neuronal loss in one-third and incidental Lewy bodies in one-sixth of community-dwelling elderly and identified nigral pathology as major contributor to the loss of motor function in old age [4]. Accordingly, in our cohort increased SN-echogenicity was found in one-quarter of subjects [8] and we here demonstrate its close relation to the development of MPS, mainly bradykinesia and rigidity. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mild parkinsonian signs (MPS) are common in the elderly population and are associated with a wide range of adverse health outcomes, including incident Parkinson's disease (PD). We aimed to prospectively evaluate potential risk factors for incident MPS. Participants of the population-based Bruneck Study representative for the general elderly community underwent a baseline assessment of substantia nigra (SN)-echogenicity with transcranial sonography, olfactory function with the Sniffin' Sticks identification test and vascular risk according to the Framingham risk score as well as a baseline and 5-year follow-up neurological examination. MPS were defined according to established criteria based on the entire motor section of the Unified PD Rating Scale. Participants with PD at baseline or follow-up and subjects with MPS at baseline were excluded. A logistic regression analysis adjusted for age and sex was used to detect risk factors for incident MPS in the remaining 393 participants. SN-hyperechogenicity and hyposmia were related to the development of MPS with odds ratios of 2.0 (95%CI, 1.1-3.7) and 1.6 (95%CI, 1.0-2.7), respectively, while increased vascular risk was not. Having both, SN-hyperechogenicity and hyposmia, was associated with an odds ratio of 3.0 (95%CI, 1.2-7.7) for incident MPS. Among the various motor domains, increased SN-echogenicity predicted the development of bradykinesia and rigidity, whereas diminished olfactory function predicted the development of impaired axial motor function. In addition to their established roles as risk factors for PD, SN-hyperechogenicity and hyposmia are associated with an increased risk for MPS in the general elderly community. Copyright © 2015 Elsevier Ltd. All rights reserved.
    Full-text · Article · Dec 2014 · Parkinsonism & Related Disorders
Show more